Suppr超能文献

随机对照试验5:确定临床试验和队列研究的样本量与检验效能

Randomized controlled trials 5: Determining the sample size and power for clinical trials and cohort studies.

作者信息

Greene Tom

机构信息

Division of Epidemiology, Internal Medicine, School of Medicine, University of Utah, Williams Building, 295 Chipeta Way, Salt Lake City, UT, 84108, USA,

出版信息

Methods Mol Biol. 2015;1281:225-47. doi: 10.1007/978-1-4939-2428-8_13.

Abstract

Performing well-powered randomized controlled trials is of fundamental importance in clinical research. The goal of sample size calculations is to assure that statistical power is acceptable while maintaining a small probability of a type I error. This chapter overviews the fundamentals of sample size calculation for standard types of outcomes for two-group studies. It considers (1) the problems of determining the size of the treatment effect that the studies will be designed to detect, (2) the modifications to sample size calculations to account for loss to follow-up and nonadherence, (3) the options when initial calculations indicate that the feasible sample size is insufficient to provide adequate power, and (4) the implication of using multiple primary endpoints. Sample size estimates for longitudinal cohort studies must take account of confounding by baseline factors.

摘要

开展具有足够检验效能的随机对照试验在临床研究中至关重要。样本量计算的目的是确保统计检验效能可接受,同时保持I类错误的概率较小。本章概述了两组研究标准类型结局的样本量计算基础。它考虑了以下几个方面:(1)确定研究旨在检测的治疗效果大小的问题;(2)为考虑失访和不依从对样本量计算进行的调整;(3)当初始计算表明可行的样本量不足以提供足够的检验效能时的选择;(4)使用多个主要终点的影响。纵向队列研究的样本量估计必须考虑基线因素的混杂作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验